Dr Jamie Bellinge
Advanced Trainee in Nuclear Medicine, Sir Charles Gairdner Hospital
Clinical Lecturer, The University of Western Australia
Research Overview
Dr Bellinge's research is focused on the development of novel molecular imaging technologies to diagnose and help treat many cardiovascular diseases. Dr Bellinge has helped develop a new technique for detecting very early calcium build up within the coronary arteries, identifying those patients who might be at very high risk of developing cardiovascular disease several years in advance and he has used this technique to trial new therapies to stop calcium build up.
Dr Bellinge is currently leading a world-first study, aimed to investigate a molecular technology tool that may help understand what leads to the development of severe peripheral artery calcification. He is also helping to develop automated imaging techniques for molecular imaging studies and working closely with his bioengineering colleagues to improve the capabilities of imaging techniques of the coronary arteries.
In 2024, Dr Bellinge will be working with international colleagues on a new imaging technique for detecting blood clots in the heart and lungs.
Dr Bellinge aims to continue to develop and improve molecular imaging techniques to allow early detection of several cardiovascular diseases, including coronary artery disease, peripheral artery disease, strokes, deep vein thromboses, pulmonary emboli and valve disorders. He hopes to see some of these technologies be used as endpoints in the trial of new and established therapies and be used to monitor response to treatment and disease progression.
Ultimately, Dr Brllinge aims to use this fascinating and novel technology to reduce the burden of cardiovascular disease in Australia.